Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function

Psychopharmacology

Volumn 169, Issue 1, 2003, Pages 91-103

  Curran, H Valerie ^a   Verheyden, Suzanne L ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

5 HT; Abstention; Cognition; Ecstasy; Ex users; MDMA; Memory; Serotonin; Tryptophan

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; SEROTONIN; TRYPTOPHAN;

AGGRESSION; ARTICLE; BLOOD LEVEL; COGNITION; CORRELATION ANALYSIS; DRUG WITHDRAWAL; IMPULSIVENESS; INTELLIGENCE QUOTIENT; LEARNING; MOOD; PRIORITY JOURNAL; SUPPLEMENTATION; TRYPTOPHAN METABOLISM; WORKING MEMORY;

ADULT; AFFECT; AMPHETAMINE-RELATED DISORDERS; ATTENTION; COGNITION; HALLUCINOGENS; HUMANS; MALE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SEROTONIN; TIME FACTORS; TRYPTOPHAN; VERBAL BEHAVIOR;

EID: 0041874887     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1463-5     Document Type: Article

References (65)

1. Anderson IM, Parry-Billings M, Newsholme EA, Fairburn CG, Cowen PJ (1990) Dieting reduces plasma tryptophan and alters brain 5-HT function in women. Psychol Med 20:785-791
2. Barratt ES, Patton JH (1983) Impulsivity: cognitive, behavioural and psychophysiological correlates. In: Zucherman M (ed) Biological basis of sensation feeling, impulsivity and anxiety. Erlbaum, Hillsdale, NJ
3. Battaglia G, Yeh SY, de Souza EB (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29:269-274
4. Battig WF, Montague WE (1969) Category norms of verbal items in 56 categories. A replication and extension of the Connecticut category norms. J Exp Psychol 80:1-46
5. Beck AT (1978) The Beck Depression Inventory (BDI). The Psychological Corporation, Harcourt Brace Jovanovitz, USA
6. Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN (1994) Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 51:687-697
7. Bhattachary S, Powell JH (2001)Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or "ecstasy": evidence for cognitive impairment. Psychol Med 31:647-658
8. Bolla KI, McCann UD, Ricaurte GA (1998) Memory impairments in abstinent MDMA ("ecstasy") users. Neurology 51:1532-1537
9. Bond AJ, Lader MH (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211-218
10. Bond AJ, Wingrove J, Critchlow DG (2001) Tryptophan depletion increases aggression in women during the premenstrual phase. Psychopharmacology 156:477-480
11. Buhot MC (1997) Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 7:243-254
12. Buschke H, Fuld PA (1974) Evaluating storage, retention and retrieval in disordered memory and learning. Neurology 11:1019-1025
13. Buss AH, Perry M (1992) The aggression questionnaire. J Person Soc Psychol 63:452-459
14. Cleare AJ, Bond AJ (1995) The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects. Psychopharmacology 118:72-81
15. Croft RJ, Mackay AJ, Mills AT, Gruzelier JG (2001) The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153:373-379
16. Curran HV (2000) Is MDMA ("ecstasy") neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology 42:34-41
17. Curran HV, Hildebrandt M (1999) Dissociative effects of alcohol on recollective experience. Conscious Cognit 8:497-509
18. 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology 164:61-70
19. Davison D, Parrott AC (1997) Ecstasy (MDMA) in recreational users: self-reported psychological and physiological effects. Hum Psychopharmacol 12:221-226
20. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990) Serotonin function and the mechanism of antidepressant action. Arch Gen Psychiatry 47:411-418
21. Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger GR, Charney DS (1994) Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 51:865-873
22. Fernstrom JD, Wurtman RJ (1972) Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178:414-416
23. Fletcher JM, Page JB, Francis DJ, Copeland K, Naus MJ, Davis CM, Morris R, Krauskopf D, Satz P (1996) Cognitive correlates of long-term cannabis use in Costa Rican men. Arch Gen Psychiatry 53:1051-1057
24. Gartside SE, Cowen PJ, Sharp T (1992) Effects of 5-hydroxy-L-tryptophan on the release of 5-HT in rat hypothalamus in vivo as measured by microdialysis. Neuropharmacology 31:9-14
25. Gerra G, Zaimovic A, Giucastro G, Maestri D, Monica C, Sartori R, Caccavari R, Delsignore R (1998) Serotonergic function after (±)3,4-methylene-dioxymethamphetamine ("ecstasy") in humans. Int Clin Psychopharmacol 13:1-9
26. Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert H-J, Fimm B, Sass H (2000) Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). J Neurol Neurosurg Psychiatry 68:719-725
27. Green AR, Cross AJ, Goodwin GM (1995) Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"). Psychopharmacology 19:247-260
28. Grob CS (2000) Deconstructing ecstasy: the politics of MDMA research. Addict Res :549-588
29. Hatzidimitriou G, McCann LID, Ricaurte GA (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (±)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19:5096-5107
30. Klaassen T, Riedel WJ, Deutz NE, van Someron A, van Praag HM (1999) Specificity of the tryptophan depletion method. Psychopharmacology 141:279-286
31. Klugman, A, Hardy S, Baldeweg T, Gruzelier J (1999) Toxic effect of MDMA on brain serotonin neurons. Lancet 353:1269-1270
32. Liechti ME, Gamma A, Vollenweider FX (2001) Gender differences in the subjective effects of MDMA. Psychopharmacology 154:161-168
33. Liester MB, Grob CS, Bravo GL, Walsh RN (1992) Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use. J Nerv Ment Dis 180:345-352
34. McCann, UD, Ridenour A, Shaham Y, Ricaurte GA (1994) Serotonin neurotoxicity after (±)3,4- methylenedioxymethamphetamine (MDMA; "ecstasy"): a controlled study in humans. Neuropsychopharmacology 10:129-138
35. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomographic evidence of toxic effect of MDMA ("ecstasy") on brain serotonin neurons in human beings. Lancet 352:1433-1437
36. Meneses A (1999) 5-HT system and cognition. Neurosci Biobehav Rev 23:1111-1125
37. Moja EA, Cipolla P, Castoldi D, Tofanetti O (1989) Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats. Life Sci 44:971-976
38. Morgan MJ (1999) Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology 141:30-36
39. Morgan MJ, McFie L, Fleetwood H, Robinson J (2002) Ecstasy (MDMA) are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology 159:294-303
40. Nelson HE (1982) The national adult reading test (NART): test manual. NFER-Nelson, Windsor, UK
41. O'Shea E, Granados R, Esteban B, Colado MI, Green AR (1998) The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ("ecstasy"). Neuropharmacology 37:919-926
42. Park SB, Coull JT, McShane RH, Young AH, Sahakian BJ, Robbins TW, Cowen PJ (1994) Tryptophan depletion in normal volunteers produces selective impairments in learning and memory. Neuropharmacology 33:575-588
43. Parrott AC, Lees A, Garnham NJ, Jones M, Wesnes K (1998) Cognitive performance in recreational users of MDMA or "ecstasy": evidence for memory deficits. J Psychopharmacol 12:79-83
44. Reidel WJ, Klaassen T, Deutz NE, van Someren A, van Praag HM (1999) Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology 141:362-369
45. Reilly JG, McTavish SF, Young AH (1997) Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. J Psychopharmacol 11:381-392
46. Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den-Heeten GJ, Booij J (2001) Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. Arch Gen Psychiatry 58:901-906
47. Ricaurte GA, Yuan J, McCann UD (2000) (± )3,4-Methylenedioxymethamphetamine ("ecstasy")-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5-10
48. Ricaurte GA, Yuan J, Hatzidimitriou G, Cord B, McCann UD (2002) Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy"). Science 297:2260-2263
49. Rodgers J (2000) Cognitive performance amongst recreational users of "ecstasy". Psychopharmacology 151:19-24
50. Scheffel U, Szabo Z, Matthews WB, Finley PA, Dannals RF, Ravert HT, Szabo K, Yuan J, Ricaurte GA (1998) In vivo detection of short and long-term MDMA neurotoxicity - a positron emission tomography study in the living baboon brain. Synapse 29:183-192
51. Schmitt JA, Jorissen BL, Sobczak S, van Boxtel M P, Hogervorst E, Deutz NE, Riedel WJ (2000) Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers. J Psychopharmacol 14:21-29
52. Shansis FM, Busnello JV, Quevedo J, Young S, Izquierdo I, Kapczinski F (2000) Behavioural effects of acute tryptophan depletion in healthy volunteers. J Psychopharmacol 14:157-163
53. Smith KA, Fairburn CG, Cowen PJ (1997) Relapse of depression after rapid depletion of tryptophan. Lancet 349:915-919
54. Speilberger C, Garsuch R, Lushene R (1970) Manual for the state-trait anxiety inventory. Consulting Psychologists Press, Palo Alto, California
55. Tiihonen J, Virkkunen M, Rasanen P, Pennanen S, Sainio E-L, Callaway J, Halonen P, Liesivuori J (2001) Free L-tryptophan plasma levels in antisocial violent offenders. Psychopharmacology 157:395-400
56. Verheyden S, Hadfield J, Callin T, Curran HV (2002) Sub-acute effects of "ecstasy" (+3,4 methylenedioxymethamphetamine) on mood: evidence of gender differences. Psychopharmacology 161:23-31
57. Verheyden S, Maidment R, Curran HV (2003) Quitting ecstasy: an investigation of why people stopped taking the drug and their subsequent mental health. J Psychopharmacol (in press)
58. Wareing M, Fisk JE, Murphy PN (2000) Working memory deficits in current and previous users of MDMA ("ecstasy"). Br J Psychol 91:181-188
59. Wesnes K, Warburton DM (1983) Effects of smoking on rapid visual information processing performance. Neuropsychobiology 9:233-229
60. Williams WA, Shoaf SE, Hommer D, Rawlings R, Linnoila M (1999) Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J Neurochemistry 72:1641-1647
61. Wilson B, Cockburn J, Baddeley A (1985) The Rivermead behavioural memory test. Thames Valley Text, Reading, UK
62. Wolff K, Hay AW, Sherlock K, Conner M (1995) Contents of "ecstasy". Lancet 346:1100-1101
63. Young SN, Gautier S (1981) Effect of tryptophan administration on tryptophan, 5- hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 44:323-327
64. Young SN, Smith SE, Pihl RO, Ervin FR (1985) Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87:173-177
65. Zakzanis KK, Young DA (2001) Memory impairment in abstinent MDMA ("ecstasy!) users: a longitudinal investigation. Neurology 56:966-969